Cargando…

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

BACKGROUND: Macrophages play a significant role in liver disease development and progression. The macrophage activation marker soluble (s)CD163 is associated with severity and prognosis in a number of different acute and chronic liver diseases but has been only sparsely examined in Wilson’s disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glavind, Emilie, Gotthardt, Daniel N., Pfeiffenberger, Jan, Sandahl, Thomas Damgaard, Bashlekova, Teodora, Willemoe, Gro Linno, Hasselby, Jane Preuss, Weiss, Karl Heinz, Møller, Holger Jon, Vilstrup, Hendrik, Lee, William M., Schilsky, Michael L., Ott, Peter, Grønbæk, Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331244/ https://www.ncbi.nlm.nih.gov/pubmed/32615997 http://dx.doi.org/10.1186/s13023-020-01452-2

Ejemplares similares

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
por: Björklund, Jessica, et al.
Publicado: (2018)

Case report: Huppke–Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years
por: Kirk, Frederik Teicher, et al.
Publicado: (2022)

Designing Clinical Trials in Wilson’s Disease
por: Ott, Peter, et al.
Publicado: (2021)

The pathophysiology of Wilson’s disease visualized: A human (64)Cu PET study
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2022)

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2017)

A rare missense variant in APC interrupts splicing and causes AFAP in two Danish families
por: Djursby, Malene, et al.
Publicado: (2020)

Edging closer to successful gene therapy for Wilson disease
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2022)

Alterations of lipid metabolism in Wilson disease
por: Seessle, Jessica, et al.
Publicado: (2011)

Distribution of non-ceruloplasmin-bound copper after i.v. (64)Cu injection studied with PET/CT in patients with Wilson disease
por: Munk, Ditte Emilie, et al.
Publicado: (2023)

Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis
por: Glavind, Emilie, et al.
Publicado: (2016)

Comparative assessment of clinical rating scales in Wilson’s disease
por: Volpert, Hanna M., et al.
Publicado: (2017)

No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation
por: Støy, Sidsel, et al.
Publicado: (2021)

HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson’s Disease
por: Ferenci, Peter, et al.
Publicado: (2019)

Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course
por: Støy, Sidsel, et al.
Publicado: (2013)

Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes
por: Svendsen, Pia, et al.
Publicado: (2016)

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
por: Svart, Mads, et al.
Publicado: (2018)

The Challenges of Diagnosing and Following Wilson Disease in the Presence of Proteinuria
por: Khan, Soofia, et al.
Publicado: (2016)

The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis
por: Bossen, Lars, et al.
Publicado: (2023)

Intrapancreatic accessory spleen mimicking malignant tumor: three case reports
por: Zurek Munk-Madsen, Maria, et al.
Publicado: (2019)

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020)

Noninvasive Prediction of Advanced Fibrosis in Pediatric Liver Disease—Discriminatory Performance of 2D Shear Wave Elastography, Transient Elastography and Magnetic Resonance Elastography in Comparison to Histopathology
por: Nielsen, Jon, et al.
Publicado: (2022)

Prospective Pilot Study of a Single Daily Dosage of Trientine for the Treatment of Wilson Disease
por: Ala, Aftab, et al.
Publicado: (2015)

Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
por: Rittig, Nikolaj, et al.
Publicado: (2017)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

A Case for Not Going Global: “Americanization” of Diet Accelerates Hepatic Mitochondrial Injury in a Model of Wilson Disease
por: To, Uyen, et al.
Publicado: (2019)

Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature
por: Boga, Salih, et al.
Publicado: (2015)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
por: Kazankov, Konstantin, et al.
Publicado: (2022)

Zinc Maintenance Therapy for Wilson Disease: A Comparison Between Zinc Acetate and Alternative Zinc Preparations
por: Camarata, Michelle A., et al.
Publicado: (2019)

Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
por: Munk, Ditte Emilie, et al.
Publicado: (2022)

Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment
por: Boga, Salih, et al.
Publicado: (2015)

Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype–phenotype relationship
por: Vogel, Ida, et al.
Publicado: (2017)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
por: Ørntoft, Nikolaj Worm, et al.
Publicado: (2021)

Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases
por: Laursen, Tea Lund, et al.
Publicado: (2022)

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease
por: Christensen, Claus Uhrenholt, et al.
Publicado: (2018)

Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression
por: Støy, Sidsel, et al.
Publicado: (2020)

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
por: Paternostro, Rafael, et al.
Publicado: (2020)

Wilson's Disease
por: Glazebrook, A. J.
Publicado: (1945)

Wilson's Disease
por: Vukasovic, Ines
Publicado: (2004)

Wilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters
por: Bekele, Nebiyu, et al.
Publicado: (2020)

Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [(64)Cu]copper PET/CT
por: Kjærgaard, Kristoffer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q8uat5gl3j8as8o89fgciq3peo